What sets your company apart, and how does your process differ from other patient education companies?

PRIMR’s approach to ensuring low-risk content approval by IRBs involves rigorous processes and adherence to regulatory standards.

With a track record of 100% IRB approval on first submission for our content over 4 years, PRIMR demonstrates its commitment to compliance and quality assurance.

PRIMR employs thorough review processes, collaboration with key opinion leaders in our network, and adherence to industry best practices to achieve consistent approval rates. Other content vendors lack oncology expertise, outsource expert review, slowing down the process, increasing costs and lowering the ultimate quality of the product and impact on patient understanding.

Other FAQs

Is PRIMR trying to replace the doctor patient relationship with a video?

PRIMR supplements the in person encounter with an additional layer of digital patient education that can be consumed asynchronously offline, on demand and shared with friends and family at scale.

Is your content IRB approved?

Yes - all of our content for clinical trials is IRB approved. We guarantee IRB approval and historically have a 100% success rate. Speed of approval wholly depends on IRB. Non-clinical trial (general education) content does not need IRB approval.

How will I know if patients are engaged with PRIMR content?

For clinical trial recruitment, PRIMR tracks patient engagement data including impressions, views, % viewed and geolocation. We report data out to PIs and sponsors monthly. Our analytics show patients watch PRIMR videos 1.9 times on average, suggesting very high level of engagement.